Cancer Letters

Homologous cancer cell membrane-camouflaged nanoparticles target drug delivery and enhance the chemotherapy efficacy of hepatocellular carcinoma

Publication date: Available online 24 February 2023Source: Cancer LettersAuthor(s): Yahui Wu, Rongtao Zhu, Mengyang Zhou, Jingjing Liu, Kai Dong, Senfeng Zhao, Jiahui Cao, Weijie Wang, Chenguang Sun, Shitao Wu, Fan Wang, Yupeng Shi, Yuling Sun

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma

Publication date: Available online 24 February 2023Source: Cancer LettersAuthor(s): Boxin Zhang, Hao Li, Yuan-Tong Liu, Dian Xiong, Lu Zhang, Zhi-Jun Sun

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Tumor-targeted exosomes for delivery of anticancer drugs

Publication date: Available online 21 February 2023Source: Cancer LettersAuthor(s): Rajeswari Raguraman, Dhaval Bhavsar, Dongin Kim, Xiaoyu Ren, Vassilios Sikavitsas, Anupama Munshi, Rajagopal Ramesh

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Editorial Board

Publication date: 31 March 2023Source: Cancer Letters, Volume 557Author(s):

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Retraction notice to “Endogenous production of C–C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis” [Canc. Lett. 468 (2020) 27–40]

Publication date: Available online 21 February 2023Source: Cancer LettersAuthor(s): Shan-Shan Guo, Rui Liu, Yue-Feng Wen, Li-Ting Liu, Li Yuan, Yan-Xian Li, Yang Lie, Wen-Wen Hao, Jing-Yun Peng, Dan-Ni Chen, Qing-Nan Tang, Xue-Song Sun, Ling Guo, Hao-Y…

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Retraction notice to “HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma” [Cancer Lett. 453 (2019) 10–20]

Publication date: Available online 21 February 2023Source: Cancer LettersAuthor(s): Haotian Wang, Rujiang Jia, Tiansuo Zhao, Xin Li, Mingxiao Lang, Chungen Lan, Hongwei Wang, Zengun Li, Bodong Zhou, Liangliang Wu, Yan Sun, Xiuchao Wang, He Ren, Jihui Hao

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Retraction notice to “Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway” [Canc. Lett. 436 (2018) 119–128]

Publication date: Available online 21 February 2023Source: Cancer LettersAuthor(s): Xiao Tan, Zhongqiang Zhang, Hongliang Yao, Liangfang Shen

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia

Publication date: Available online 17 February 2023Source: Cancer LettersAuthor(s): Rui Zhang, Qingxi Liu, Sa Zhou, Hongpeng He, Mingfeng Zhao, Wenjian Ma

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

Lymphocyte antigen 6K signaling to aurora kinase promotes advancement of the cell cycle and the growth of cancer cells, which is inhibited by LY6K-NSC243928 interaction

Publication date: Available online 16 February 2023Source: Cancer LettersAuthor(s): Benson Chellakkan Selvanesan, Sheelu Varghese, Justyna Andrys-Olek, Ricardo Hernandez Arriaza, Rahul Prakash, Purushottam Babu Tiwari, Daniel Hupalo, Yuriy Gusev, Megha…

By ScienceDirect Publication: Cancer Letters, 2 years ago

Cancer Letters

N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer

Publication date: Available online 15 February 2023Source: Cancer LettersAuthor(s): Jing Yang, Penghui Xu, Zetian Chen, Xing Zhang, Yiwen Xia, Lang Fang, Li Xie, Bowen Li, Zekuan Xu

By ScienceDirect Publication: Cancer Letters, 2 years ago